A series of 4'-[(imidazol-1-yl)methyl]biphenylsulfonamides has potent antagonist activity against both angiotensin II AT(1) and endothelin ET(A) receptors. Such dual-acting antagonists could have utility in the treatment of hypertension, heart failure, and other cardiovascular diseases in a broad patient population. Certain compounds in the present series are orally active in a rat model of angiotensin II-mediated hypertension.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0960-894x(03)00018-0 | DOI Listing |
Publication Analysis
Top Keywords
discovery 4'-[imidazol-1-ylmethyl]biphenyl-2-sulfonamides
4
4'-[imidazol-1-ylmethyl]biphenyl-2-sulfonamides dual
4
dual endothelin/angiotensin
4
endothelin/angiotensin receptor
4
receptor antagonists
4
antagonists series
4
series 4'-[imidazol-1-ylmethyl]biphenylsulfonamides
4
4'-[imidazol-1-ylmethyl]biphenylsulfonamides potent
4
potent antagonist
4
antagonist activity
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!